Global Thrombophilia Market Projected to Surpass $25.12 Billion by 2029 with 8% Annual Growth

Which drivers are expected to have the greatest impact on the over the thrombophilia market's growth?
The forecasted rise in the population of older adults is set to stimulate the thrombophilia market's expansion. Typically, the elderly population is categorized as individuals aged 65 or older, and the dependent populace is calculated by expressing the combined total of the elderly and young segments of the population as a percentage of the overall population. The prevalence of thrombophilic risk factors among older adults aids in identifying those more susceptible to adverse clinical outcomes, hence increasing demand for thrombophilia treatments as the elderly population grows. For example, America's Health Rankings, a US health outcomes evaluating organization, released data in 2022 confirming that over 56 million adults over the age of 65 make up approximately 16.9% of the overall US population. This population is expected to exceed 73.1 million by 2030. Consequently, the thrombophilia market's growth is powered by the expanding elderly population.

https://www.thebusinessresearchcompany.com/report/thrombophilia-global-market-report

What is the future CAGR of the thrombophilia market, and how will it impact industry expansion?
The market size of thrombophilia has steadily increased over the past few years. A rise from $17.03 billion in 2024 to $18.35 billion in 2025 with a compound annual growth rate (CAGR) of 7.7% is anticipated. The noticeable growth in the earlier period is largely due to an elevated level of awareness, advancements in anticoagulant therapies research and development, the aging demographic, genetic studies, along with a rise in thrombotic disorder cases.

There is an anticipation of a robust surge in the thrombophilia market in the upcoming years. The market is projected to attain a value of $25.12 billion by 2029, registering a compound annual growth rate (CAGR) of 8.2%. This projected growth during the forecast period is primarily due to personalised medical treatments, the unveiling of new therapies, the implementation of artificial intelligence, healthcare policies and regulations, along with greater patient awareness and empowerment. The forecast period will also witness trends like advanced technologies, an extended influence of telemedicine, increasing occurrence rates, progress in biopharmaceutical, and combined research initiatives.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9439&type=smp

What are the most significant trends transforming the thrombophilia market today?
The thrombophilia market is witnessing a dominant trend in the form of technological advancements. Key players in the market are harnessing innovative technologies in an effort to maintain their market standing. One such remarkable progress was made by researchers of the University of California, San Diego, in May 2023, where they introduced a game-changing technology called Eloctate. This revolutionary method employs a unique fusion protein that greatly uplifts the stability and half-life of coagulation factors in the bloodstream. Their objective is to pair this technology with existing treatments to generate drugs with a prolonged action that need less frequent doses, thus enhancing patient adherence and overall wellbeing.

Which key market segments comprise the thrombophilia market and drive its revenue growth?
The thrombophilia market covered in this report is segmented -

1) By Type: Factor V Leiden, Prothrombin 20210, Antiphospholipid Syndrome, Other Type
2) By Drugs: Heparin, Warfarin, Other Drugs
3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration
4) By End-Users: Hospitals, Homecare, Specialty Centers, Other End Users

Subsegments:
1) By Factor V Leiden: Genetic Testing, Anticoagulant Therapy
2) By Prothrombin 20210: Genetic Testing, Anticoagulant Therapy
3) By Antiphospholipid Syndrome: Antiphospholipid Antibody Testing, Anticoagulant Therapy
4) By Other Types: Protein C Deficiency, Protein S Deficiency, Antithrombin III Deficiency, Other Genetic Conditions

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9439

What regions are at the forefront of thrombophilia market expansion?
North America was the largest region in the thrombophilia market in 2024. The regions covered in the thrombophilia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Who are the leading players fueling growth in the thrombophilia market?
Major companies operating in the thrombophilia market include Pfizer Inc., F. Hoffmann-La Roche Limited, Changzhaou Qianhong Bio-pharma Co. Limited, Fresenius Kabi AG, Hebei Changshan Biochemical Pharmaceutical Co. Limited, Hikma Pharmaceuticals PLC., Novartis AG, Shanghai Fosun Pharmaceutical (Group) Co. Ltd., Shenzhen Hepalink Pharmaceutical Group Co. Limited, Teva Pharmaceutical Industries Limited, Yino Pharma Limited, Sanofi SA, Eisai Co. Limited, Boehringer Ingelheim GmbH, Instrumentation Laboratory SpA, Johnson & Johnson, Laurus Lab, Bristol-Myers Squibb, Roche, Abbott, C. H. Boehringer Sohn, Portola Pharmaceuticals, Daiichi Sankyo, Bayer Group, GlaxoSmithKline plc, CSL Behring

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=9439&type=smp

What Is Covered In The Thrombophilia Global Market Report?

• Market Size Forecast: Examine the thrombophilia market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the thrombophilia market for a structured understanding.
• Key Players Overview: Analyze major players in the thrombophilia market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the thrombophilia market.
• Segment Contributions: Evaluate how different segments drive overall growth in the thrombophilia market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the thrombophilia market.
• Industry Challenges: Identify potential risks and obstacles affecting the thrombophilia market.
• Competitive Landscape: Review strategic developments in the thrombophilia market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.